1132941-18-4

Basic information

• Product Name: 3-tert-butyl-5-(2,4-dioxotetrahydropyrimidin-1(2H)-yl)-2-methoxybenzaldehyde
• Synonyms: 3-tert-butyl-5-(2,4-dioxotetrahydropyrimidin-1(2H)-yl)-2-methoxybenzaldehyde
• CAS NO: 1132941-18-4
• Molecular Weight: 304.346
• Mol File: 1132941-18-4.mol
• Article Data: 4

Chemical Properties

• CAS DataBase Reference: 3-tert-butyl-5-(2,4-dioxotetrahydropyrimidin-1(2H)-yl)-2-methoxybenzaldehyde(CAS DataBase Reference)
• NIST Chemistry Reference: 3-tert-butyl-5-(2,4-dioxotetrahydropyrimidin-1(2H)-yl)-2-methoxybenzaldehyde(1132941-18-4)
• EPA Substance Registry System: 3-tert-butyl-5-(2,4-dioxotetrahydropyrimidin-1(2H)-yl)-2-methoxybenzaldehyde(1132941-18-4)

Safety Data

• Hazardous Substances Data: 1132941-18-4(Hazardous Substances Data)

Upstream product

• 1132941-14-0 methyl 3-tert-butyl-5-(2,4-dioxotetrahydropyrimidin-1(2H)-yl)-2-methoxybenzoate 
• 1132941-85-5 3-(3-tert-butyl-4-methoxy-5-(methoxycarbonyl)phenylamino)propanoic acid 
• 1132941-00-4 3-tert-butyl-2-methoxy-5-nitrobenzoate 
• 372137-83-2 methyl 3-tert-butyl-2-hydroxy-5-nitrobenzoate 
• 1132941-02-6 methyl 5-amino-3-tert-butyl-2-methoxybenzoate 
• 15018-03-8 methyl 3,5‐di‐tert-butyl‐2‐hydroxybenzoate 
• 1132941-16-2 3-tert-butyl-5-(2,4-dioxotetrahydropyrimidin-1(2H)-yl)-2-methoxybenzoic acid 
• 1132945-26-6 3-tert-butyl-5-(2,4-dioxotetrahydropyrimidin-1(2H)-yl)-2methoxybenzoylchloride 

Downstream Products

• 1132935-67-1 1-(3-tert-butyl-4-methoxy-5-(6-nitrobenzo[d]oxazol-2-yl)phenyl)dihydropyrimidine-2,4(1H,3H)-dione 
• 1132935-73-9 N-(2-(3-tert-butyl-5-(2,4-dioxotetrahydropyrimidin-1(2H)-yl)-2-methoxyphenyl)benzo[d]thiazol-6-yl)methanesulfonamide 
• 1132935-74-0 N-(2-(3-tert-butyl-5-(2,4-dioxotetrahydropyrimidin-1(2H)-yl)-2-methoxyphenyl)benzo[d]thiazol-5-yl)methanesulfonamide 
• 1132945-36-8 (E)-1-(3-(tert-butyl)-4-methoxy-5-(2-(4-nitrophenyl)prop-1-en-1-yl)phenyl)dihydropyrimidine-2,4(1H,3H)-dione 
• 1132939-87-7 N-(4-((3-(tert-butyl)-5-(2,4-dioxotetrahydropyrimidin-1(2H)-yl)-2-methoxybenzyl)amino)phenyl)methanesulfonamide 
• 1132937-18-8 (E)-N-(4-(1-(3-(tert-butyl)-5-(2,4-dioxotetrahydropyrimidin-1(2H)-yl)-2-methoxyphenyl)prop-1-en-2-yl)phenyl)methanesulfonamide 
• 1132939-83-3 N-(4-((3-(tert-butyl)-5-(2,4-dioxotetrahydropyrimidin-1(2H)-yl)-2-methoxybenzyl)oxy)phenyl)methanesulfonamide 
• 1132941-90-2 (E)-1-(3-tert-butyl-4-methoxy-5-(4-nitrostyryl)phenyl)dihydropyrimidine-2,4(1H,3H)-dione 

Relevant articles and documents

Synthesis and Biological Characterization of Aryl Uracil Inhibitors of Hepatitis C Virus NS5B Polymerase: Discovery of ABT-072, a trans-Stilbene Analog with Good Oral Bioavailability

ABT-072 is a non-nucleoside HCV NS5B polymerase inhibitor that was discovered as part of a program to identify new direct-acting antivirals (DAAs) for the treatment of HCV infection. This compound was identified during a medicinal chemistry effort to impr

URACIL OR THYMINE DERIVATIVE FOR TREATING HEPATITIS C

Present application relates to the compounds of formula I useful to treat hepatitis C (HCV) infections. In the structure of the disclosed compounds is the uracil or thymine derivative linked via a phenylene into either fused 2-ring cyclic system (R6) or alternatively via additional two-atom linker (L) to a 5-6 membered monocycle (R6). Application further discloses polymorphs and pseudopolymorphs of two specific compounds: N-(6(3-t-butyl-5-(2>4-dioxo-3,4-dihydropyrimidin-1 (2H)- y!)2-methoxy-phenyl)naphthalen-2-yl)methanesulfonamide and (E)-N-(4(3-t- butyl-5-(2,4-dioxo-3)4-dihydropyrimidin-1 (2H)-yl)2-methoxy-styryl- phenyl)methanesulfonamide.